Ocugen to Participate in a Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference

Core Insights - Ocugen, Inc. is participating in the H.C. Wainwright 26th Annual Global Investment Conference from September 9-11, 2024, in New York, NY, where Dr. Shankar Musunuri will engage in a fireside chat [1][2] - The conference serves as a platform for Ocugen to showcase its recent corporate achievements and future milestones, with one-on-one meetings planned for investors [2] Event Details - The fireside chat is scheduled for September 9, 2024, at 1:30 p.m. ET, located at the Lotte New York Palace Hotel [3] - A live video webcast of the presentation will be available on Ocugen's investor site, with a replay archived for 90 days [3] Company Overview - Ocugen, Inc. focuses on discovering, developing, and commercializing novel gene and cell therapies, and vaccines aimed at improving global health [4] - The company is advancing a unique modifier gene therapy platform that has the potential to treat multiple retinal diseases with a single product, alongside research in infectious and orthopedic diseases [4]